- Home
- WRAP vs PMVP Comparison
WRAP vs PMVP Comparison
Compare WRAP & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- PMVP
- Stock Information
- Founded
- WRAP 2016
- PMVP 2013
- Country
- WRAP United States
- PMVP United States
- Employees
- WRAP N/A
- PMVP N/A
- Industry
- WRAP Ordnance And Accessories
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- WRAP Industrials
- PMVP Health Care
- Exchange
- WRAP Nasdaq
- PMVP Nasdaq
- Market Cap
- WRAP 68.8M
- PMVP 85.5M
- IPO Year
- WRAP N/A
- PMVP 2020
- Fundamental
- Price
- WRAP $1.70
- PMVP $1.65
- Analyst Decision
- WRAP
- PMVP Strong Buy
- Analyst Count
- WRAP 0
- PMVP 4
- Target Price
- WRAP N/A
- PMVP $5.75
- AVG Volume (30 Days)
- WRAP 191.1K
- PMVP 185.0K
- Earning Date
- WRAP 10-15-2024
- PMVP 11-07-2024
- Dividend Yield
- WRAP N/A
- PMVP N/A
- EPS Growth
- WRAP N/A
- PMVP N/A
- EPS
- WRAP N/A
- PMVP N/A
- Revenue
- WRAP $7,269,000.00
- PMVP N/A
- Revenue This Year
- WRAP N/A
- PMVP N/A
- Revenue Next Year
- WRAP N/A
- PMVP N/A
- P/E Ratio
- WRAP N/A
- PMVP N/A
- Revenue Growth
- WRAP 0.99
- PMVP N/A
- 52 Week Low
- WRAP $1.21
- PMVP $1.33
- 52 Week High
- WRAP $7.01
- PMVP $3.47
- Technical
- Relative Strength Index (RSI)
- WRAP 56.79
- PMVP 60.86
- Support Level
- WRAP $1.71
- PMVP $1.63
- Resistance Level
- WRAP $1.93
- PMVP $1.69
- Average True Range (ATR)
- WRAP 0.16
- PMVP 0.07
- MACD
- WRAP 0.01
- PMVP 0.01
- Stochastic Oscillator
- WRAP 61.70
- PMVP 52.65
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.